León ÁJL, Guerra IG, Yanes QMÁ, Calderín BRO, Gutiérrez RÁ

Language: Spanish
References: 20
Page: 417-429
PDF size: 240.05 Kb.

ABSTRACT

Introduction: atherosclerosis, endothelial dysfunction and hypertension are closely related. Endothelium-dependent vasoreactivity is an equivalent of endothelial dysfunction.
Objective: To evaluate the usefulness of baseline diameter of the brachial artery measured by ultrasonographic techniques in the diagnosis of endothelial dysfunction and subclinical vascular lesion, its association with cardiovascular risk factors, and overall cardiovascular risk.
Methods: Across-sectional analytical research was conducted in 60 newly diagnosed hypertensive patients without target organ damage. They were compared with 60 non-hypertensive subjects. Cardiovascular risk factors were screened; these patients underwent several tests such as microalbuminuria, total cholesterol, HDL cholesterol, triglycerides, non-HDL cholesterol, ultrasound measurement of carotid intima-media thickness and basal diameter of the brachial artery. The global cardiovascular risk was calculated.
Results: In the hypertensive group, males constituted 55 % of the total and in the non-hypertensive group, females accounted for 78.3 %. Microalbuminuria was present in 25 % of hypertensive subejcts by 13.3 % of patients without the disease. Higher mean values of total cholesterol and non-HDL in hypertensive subjects (4.6 mmol / L and 3.6 mmol / L, respectively) were found. The mean intima-media thickness was 0.6 mm in hypertensive patients and 0.4 mm in non hypertensive subjects. In hypertensive patients, the mean baseline brachial artery diameter was 3.8 mm versus 3.5 mm in non-hypertensive subjects. In both study groups, higher mean levels of baseline diameter of the brachial artery when there were higher mean values of HDL-cholesterol.
Conclusions: There is a positive association for total cholesterol, HDL-cholesterol, the carotid intima media thickness, microalbuminuria and global cardiovascular risk in basal diameter of the brachial artery. The determination of basal diameter of the brachial artery is concluded to show promising results as a marker of endothelial dysfunction in hypertension.

REFERENCES

1. Estadella C, Vázquez S, Oliveras A. Rigidez arterial y riesgo cardiovascular. Hipertens Riesgo Vasc. 2010;27(5):203–10.

2. Willerson JT, Kereiakes DJ. Endothelial dysfunction. Circulation. 28 Oct 2003;108(17):2060-1.

3. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, et al Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005 Jan;23(1):7-17.

4. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992 Nov 7; 340(8828):1111-5.

5. Joannides R, Constentin A, Lacob M, Compagnon P, Lahary A, Thuillez C. Influence of vascular dimension on gender difference in flow-dependent dilatation of peripherals conduit arteries. Am J Physiol Heart Circ Physiol. 2002 Apr;282(4):H1262-9.

6. Herrington DM, Fan L, Drum L, Riley WA, Pusser BE, Crouse JR, et al. Brachial flow–mediated vasodilator responses in population–based: methods, reproducibility and effects of age, gender and baseline diameter. J Cardiovasc Risk. 2001 Oct; 8(5):319-28.

7. Holubkov R, Karas RH, Pepine CJ, Rickens CR, Reichek N, Rogers WJ, et al. Large brachial artery diameter is associated with angiographic coronary artery disease in women. Am Heart J. 2002 May;143(5):802-7.

8. Yeboah J, Folsom A, Burke G, Johnson C, Polak J, Post W, et al. Predictive Value of Brachial Flow-Dilation For Incident Cardiovascular Events in Population- Based Study. Multi-Ethni Study of Atherosclerosis. Circulation. 2009 Aug 11;120(6):502-9.

9. Organización Mundial de la Salud. Prevención de las enfermedades cardiovasculares. Guía de bolsillo para la estimación y el manejo del riesgo cardiovascular. Ginebra: Organización Mundial de la Salud; 2008. [documento en Internet] ISBN 978 92 4 354728 2 [citado 28 Jul. 2014]. Disponible en: http://www.who.int/publications/list/PocketGL_spanish.pdf

10. Mendis S. The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: a global perspective. Prog Cardiovasc Dis. 2010 Jul- Aug;53(1):10-4.

11. Acevedo M, Tagle R, Kramer V, Arnaíz P, Marín A, Pino F, et al. Risk factors for a high carotid intima media thickness among healthy adults. Rev Med Chil. 2011 Mar;139(3):290-7.

12. Campuzano R, Moya JL, García-Lledó A, Salido L, Guzmán G, Tomas JP, et al. Endothelial dysfunction and intima-media thickness in relation to cardiovascular risk factors in patients without clinical manifestations of atherosclerosis. Rev Esp Cardiol. 2003 Jun;56(6):546-54.

13. Montalcini T, Gorgone G, Gazzaruso C, Garzaniti A, Pujia A. Large Brachial Artery Diameter and Metabolic Syndrome in postmenopausal women. Atherosclerosis. 2010 Jun;210(2):458-60.

14. Sentí M. El componente genético de la hipertensión. Rev Esp Cardiol Supl. 2009;9:52B-57B

15. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24;129(25 Suppl 2):S1-45.

16. Guterbaum T, Gæde P. Multiple risk factor intervention to prevent cardiovascular disease. A high powered and evidence based approach. Rev Esp Cardiol (Engl Ed). 2011 Mar;64(3):173-4.

17. Schroeder S, Enderle MD, Baumbach A, Ossen R, Herdeg C, Kuettner A, et al. Influence of vessel size, age and body mass index on the flow-mediated dilatation (FMD %) of the brachial artery. Int J Cardiol. 2000 Nov-Dec;76(2-3):219-25.

18. Vita JA, Keaney JF Jr, Larson MG, Keyes MJ, Massaro JM, Lipinska I, et al. Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation. 2004 Dec 7;110(23):3604-9.

19. Tani Y, Nakayama M, Kanno M, Kimura H, Watanabe K, Tanaka K, et al. The clinical applicability of albuminuria testing in Japanese hypertensive patients: the AVA-E study. Intern Med. 2013;52(4):425-30.

20. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF Jr, et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation. 2004 Feb 10;109(5):613-9.